Skip to main content

Paul Nadler, Fred Hassan, Richard Jay Kogan


Paul Nadler has been named vice president of medical research for Branford, Conn.-based Cellular Genomics. Nadler is the managing general partner of Nadler Pharma Associates, a consulting firm. Previously, he was chief medical officer for Kern McNeill International. Nadler holds an MD from Washington University School of Medicine.


Fred Hassan was named chief executive officer of Schering-Plough and will become chairman of the board, the company said. He will replace Richard Jay Kogan, who announced his intention to retire in November. Hassan previously was chairman and CEO of Pharmacia. Hassan holds a BS in chemical engineering from Imperial College of Science and Technology of the University of London and an MBA from Harvard University.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.